Comparison of the effects of insulin monotherapy and combination therapy with ipragliflozin and insulin on glucose toxicity in type 2 diabetes mellitus : a randomized controlled trial - Comparison of the effects of insulin monotherapy and combination therapy with ipragliflozin and insulin on glucose toxicity in type 2 diabetes mellitus : a randomized controlled trial

Osaka university medical hospital0 个研究点目标入组 40 人开始时间: 2015年9月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Patients less than 20 years old or 75 years or older, and without consent 2) BMI<20kg/m2 3) Patients with severe diabetic complication (pre-proliferative retinopathy/proliferative retinopathy, eGFR<45ml/min/1.73m2, cardiovascular/cerebrovascular disease) 4) Patiens severe liver dysfunction (AST or ALT 100 IU/L or more, or T-Bil 2.0 mg/dl or more) 5) Patients who have malignant neoplasm 6) Patients taking glucocorticoid medicine 7) Patines with malnutrition or dehydration 8) Patients who correspond to the administration contraindication of ipragliflozin or insulin 9) Woman who are pregnant, nursing or possibly pregnant 10) Patients who considered not eligible for the study by the attending doctor due to other reasons

发起方

Osaka university medical hospital